DE69707293D1 - Pyrrolo(3,2-c)chinolin-derivate - Google Patents

Pyrrolo(3,2-c)chinolin-derivate

Info

Publication number
DE69707293D1
DE69707293D1 DE69707293T DE69707293T DE69707293D1 DE 69707293 D1 DE69707293 D1 DE 69707293D1 DE 69707293 T DE69707293 T DE 69707293T DE 69707293 T DE69707293 T DE 69707293T DE 69707293 D1 DE69707293 D1 DE 69707293D1
Authority
DE
Germany
Prior art keywords
pyrrolo
chinoline derivatives
chinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69707293T
Other languages
English (en)
Other versions
DE69707293T2 (de
Inventor
Paolo Pevarello
Franco Heidempergher
Torre Arturo Della
Mario Varasi
Carmela Speciale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Publication of DE69707293D1 publication Critical patent/DE69707293D1/de
Application granted granted Critical
Publication of DE69707293T2 publication Critical patent/DE69707293T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69707293T 1996-08-05 1997-07-04 Pyrrolo(3,2-c)chinolin-derivate Expired - Fee Related DE69707293T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9616467A GB2316072B (en) 1996-08-05 1996-08-05 Pyrrolo[3,2-c]quinoline derivatives
PCT/EP1997/003639 WO1998005660A1 (en) 1996-08-05 1997-07-04 Pyrrolo(3,2-c) quinoline derivatives

Publications (2)

Publication Number Publication Date
DE69707293D1 true DE69707293D1 (de) 2001-11-15
DE69707293T2 DE69707293T2 (de) 2002-07-25

Family

ID=10798073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69707293T Expired - Fee Related DE69707293T2 (de) 1996-08-05 1997-07-04 Pyrrolo(3,2-c)chinolin-derivate

Country Status (5)

Country Link
EP (1) EP0922044B1 (de)
JP (1) JP2000515528A (de)
DE (1) DE69707293T2 (de)
GB (1) GB2316072B (de)
WO (1) WO1998005660A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716103D0 (en) * 1997-07-30 1997-10-01 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
GB0522715D0 (en) 2005-11-08 2005-12-14 Helperby Therapeutics Ltd New use
UA103026C2 (ru) * 2008-07-29 2013-09-10 Ацьенде Кимике Риуните Анджелини Франческо А.К.Р.А.Ф. С.П.А. Соединение с серотонинергической активностью, способ его получения и фармацевтическая композиция, которая его содержит
JP2015523352A (ja) * 2012-06-15 2015-08-13 ファイザー・インク Ｋａｔｉｉ阻害剤としての三環式化合物
SI3027613T1 (sl) 2013-07-25 2018-10-30 Uniwersytet Jagiellonski Derivati pirolokvinolina kot 5-HT6 antagonisti, postopek priprave in uporabe le-teh
EP3377490A1 (de) 2015-11-16 2018-09-26 Fundacion para la Investigacion Medica Aplicada Neuartige verbindungen als inhibitoren von dna-methyltransferasen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB725745A (en) * 1952-05-26 1955-03-09 Bayer Ag Pyrrolinoquinolines and processes for making same
JPH085792B2 (ja) * 1986-12-19 1996-01-24 相互薬工株式会社 逆転写酵素阻害剤
EP0430485A3 (en) * 1989-11-29 1992-01-22 Ube Industries, Ltd. Quinoline compound
DE69313316T2 (de) * 1992-02-07 1998-02-19 Mitsubishi Gas Chemical Co Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists

Also Published As

Publication number Publication date
GB9616467D0 (en) 1996-09-25
EP0922044B1 (de) 2001-10-10
GB2316072B (en) 2000-05-10
GB2316072A (en) 1998-02-18
JP2000515528A (ja) 2000-11-21
EP0922044A1 (de) 1999-06-16
DE69707293T2 (de) 2002-07-25
WO1998005660A1 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
DE69711882T2 (de) Carbolinderivate
NO983169L (no) Hetrosykel-kondenserte morfinoidderivater (31)
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK0901474T3 (da) Arylpyrimidinderivater
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
DE69720493T2 (de) Naphthyridin-derivate
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO981946D0 (no) Imidazoquinazolin-derivater
DK0891978T3 (da) 5H-Thiazol(3,2-a)pyrimidinderivativer
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
ATE212635T1 (de) 1,3,8-triazaspiro(4,5)decan-4-on-derivate
ID22131A (id) Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
BR9701675A (pt) Novos pirimido(1,2-a)indóis
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
PT931087E (pt) Novos derivados de piranosido
DE69707293D1 (de) Pyrrolo(3,2-c)chinolin-derivate
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
ATA69896A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
ATA73396A (de) 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate
BR9704674A (pt) Derivados de n-benzilazólio

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee